The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-stakeholder Workshops in 2023

Save the date for the CDDF Multi-Stakeholder workshops in 2024!

CANCER DRUG DEVELOPMENT FORUM

The leading non-competitive drug development platform working to
stimulate the advancement and accessibility of cancer treatment.

Executive Summary of the CDDF Workshop on Biomarkers in Precision Oncology (13-14 Nov 2023, NL)

The Cancer Drug Development Forum (CDDF) is delighted to announce that its executive summary of the CDDF workshop on Biomarkers in Precision Oncology (13-14 Nov 2023, NL) has been published and is available to all our stakeholders. This insightful workshop brought...

TAKE-HOME MESSAGES: CDDF Multi-Stakeholder Workshop – The Critical Role of Biomarkers in Delivering Drug Development-Related Precision Oncology

Read the take-home messages from the CDDF multi-stakeholder workshop on The critical role of Biomarkers in delivering drug development-related precision oncology:   SESSION 1: SETTING THE SCENE OF BIOMARKERS Key takeaways: Biomarkers are critical in the diagnosis...

Get an Inside Look at the CDDF Multi-Stakeholder Discussion on Innovative Oncology Trial Design

Watch the interviews with participants from the CDDF Multi-stakeholder Workshop on Innovative Oncology Trial Design (18-19 September 2023, Amsterdam) and gain valuable perspectives from diverse stakeholders in cancer drug development. Collaboration is key to...

CDDF’s New Publication: White Paper – “Empowering Involvement and Engagement of Patients with Cancer in Oncology Drug Development”

The CDDF is delighted to announce that the White Paper, “Empowering Involvement and Engagement of Patients with Cancer in Oncology Drug Development”, has been published in October 2023. It has been prepared by Prof. Mark Lawler on behalf of the Cancer Drug Development...

Key Takeaways from the CDDF Webinar on Perspectives on the new EU Health Technology Assessment HTA Regulation 2021/2282 (28 September 2023)

The Cancer Drug Development Forum (CDDF) held a live webinar on “Perspectives on the new EU Health Technology Assessment HTA Regulation 2021/2282 “ on Thursday 28 September 2023. In this webinar, Marcus Guardian and Julie Spony provided an overview of the topic...

Executive Summary of the Workshop on “Innovative Oncology Trial Designs” (September 2023, Amsterdam)

The Cancer Drug Development Forum (CDDF) has published its executive summary of the workshop on “Innovative Oncology Trial Designs.” The multi-stakeholder workshop took place on 18 - 19 September 2023 in Amsterdam, NL. The gathering brought together the community of...

CDDF Workshop on Innovative Oncology Trial Designs: Key Takeaways from Day 1’s Program

📢 The Cancer Drug Development Forum (CDDF) workshop on “Innovative Oncology Trial Designs” concluded successfully on its first day, bringing together key stakeholders in cancer drug development for in-depth discussions on a range of topics. Here are key takeaways and...

Key Takeaways from the CDDF Webinar on Critical Impacts of the IVDR Implementation on Patient Access to Clinical Trials (7 September 2023)

The Cancer Drug Development Forum (CDDF) held a live webinar on “Critical Impacts of the In Vitro Diagnostic Regulation (IVDR) Implementation on Patient Access to Clinical Trials“ on Thursday 07 September 2023. In this webinar,...

Registration is Open: AAADV-ASCO-CDDF Workshop of Global Cancer Drug Development (12-15 September 2023, Online)

📣 The CDDF is pleased to inform you that registration is open for the AAADV-ASCO-CDDF Workshop of Global Cancer Drug Development that will take place online on 12-15 September 2023. This multi-stakeholder meeting is developed jointly by AAADV, ASCO and CDDF to deep...

Key Takeaways from the CDDF Webinar on Beating Cancer In Europe – Time to Deliver (10 July 2023)

The CDDF live webinar regarding “Beating Cancer in Europe – Time to deliver” took place on 10 July 2023 and invited Dr. Alberto Costa (European Commission, IT), Prof. Mark Lawler (Queen’s University Belfast & CDDF, UK) and Teodora Kolarova (International...

CDDF Webinar: Development of Novel and Targeted Agents in Precision Cancer Prevention and Interception (June 2023)

The recording of the recent CDDF webinar on Development of Novel and Targeted Agents in Precision Cancer Prevention and Interception is available here. Enjoy the insightful lecture from Dr. Brian Cholewa (NCI,US) and CDDF’s thought-provoking discussion.

CDDF & Oncology News

Check out the recent updates within the CDDF and the latest news in the community of cancer research

CDDF Brochure

Access the CDDF Brochure here

 

Join the CDDF community to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70